You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2

Article metrics

Article menu

Download PDFPDF

Spondyloarthritis
Original article
Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2

 

Online download statistics by month:

Online download statistics by month: February 2018 to August 2024

AbstractFullPdf
Feb 201814313731
Mar 201815114671
Apr 2018646426
May 2018747722
Jun 2018555618
Jul 2018555531
Aug 2018535319
Sep 201827277
Oct 2018353515
Nov 2018878715
Dec 201815315311
Jan 20191561557
Feb 20191501497
Mar 2019606010
Apr 2019181811
May 2019333310
Jun 201939377
Jul 2019514911
Aug 2019282812
Sep 2019313110
Oct 2019373717
Nov 201921218
Dec 2019292911
Jan 2020252513
Feb 202019198
Mar 2020181811
Apr 202023236
May 202021215
Jun 202032328
Jul 2020232311
Aug 202024236
Sep 2020333212
Oct 2020333115
Nov 202038339
Dec 2020343311
Jan 2021222212
Feb 2021141410
Mar 202123226
Apr 202120187
May 202116145
Jun 202117174
Jul 202115159
Aug 202117178
Sep 20211096
Oct 2021161619
Nov 20215518
Dec 2021964
Jan 2022993
Feb 20229105
Mar 202219198
Apr 202213126
May 2022313111
Jun 202237378
Jul 2022221911
Aug 202230295
Sep 2022242532
Oct 2022282911
Nov 2022111212
Dec 202213133
Jan 2023131512
Feb 202331308
Mar 202319192
Apr 202317172
May 20238710
Jun 202313125
Jul 2023383612
Aug 2023883
Sep 2023894
Oct 202316164
Nov 2023171326
Dec 202311164
Jan 2024556
Feb 20241075
Mar 202420205
Apr 202418165
May 202414153
Jun 202420188
Jul 2024201810
Aug 2024763
Total26162573862